Several chemotherapeutic agents such as Adr, melphalan, and bortezomib were shown to induce CD155 expression on multiple myeloma cells, which was blocked by treatment with pharmacologic inhibitors of ATM/ATR-related kinases [19]. The gene discussed is ATM; the disease is plasma cell myeloma.